header logo image


Page 937«..1020..936937938939..950960..»

Ashley Furniture celebrates opening of expanded wellness center – WEAU

September 7th, 2017 11:44 pm

ARCADIA, Wis. (WEAU)-- Access to healthcare is expanding for thousands who live and work in Arcadia. This afternoon, Ashley Furniture cut the ribbon on its Ashley Wellness Center located at Arcadia's Historic St. Joseph's Hospital.

The expanded facility offers healthcare to Ashley Furniture employees and their families. Ashley Furniture chairman Ron Wanek says the wellness center is made possible thanks to a connection with Gundersen Health System. Back in 2008, Ashley partnered with Gundersen to open the first Ashley Wellness Center in Arcadia and since then they've served more than 11,000 patients.

Wanek sees the expanded facility as a beneficial investment for everyone involved. He says the facility will make health care more easily accessible to thousands of families.

We live in Arcadia where we are 45 miles away from La Crosse and 45 miles from Eau Claire. People will get healthcare here because its convenient instead of driving one way or the other they can make appointments here and stop in, Wanek explained.

Along with offering services like eye exams and physical therapy, the Ashley Wellness Center's main focus is on preventative care.

Preventative medicine is the best medicine. When you talk about health, you don't want to wait until people are sick. You want to catch those things early and have the access by being closer to home certainly helps, Dr. Scott Rathgaber, CEO of Gundersen Health System said.

The clinic will be open regularly from 6am-6 pm Monday through Friday and Saturday from 9 am to noon.

Read the original:
Ashley Furniture celebrates opening of expanded wellness center - WEAU

Read More...

Polk County people in medicine (September 5) – The Ledger – The Ledger

September 7th, 2017 11:44 pm

GESSLER CLINIC

Dr. Haldane W. Porteous has joined Gessler Clinc, PA, 635 First St. N., Winter Haven. Board certified in Internal Medicine and a Board Certified Clinical Hypertension Specialist, Porteous received his Bachelor of Medicine and Bachelor of Surgery with Honors in Basic Medical Sciences from the University of West Indies Medical School in Kingston, Jamaica and his Master of Science in Patient Safety Leadership at the University of Illinois at Chicago, completed an Internal Medicine Internship and residency at the University of Miami/Jackson Memorial Hospital in Miami and a nephrology fellowship at Johns Hopkins University School of Medicine in Baltimore. His professional affiliations include the Renal Physician Association, American Society of Nephrology, American Society of Hypertension and the American College of Physicians.

LAKE WALES MEDICAL CENTER

Shazam Abdul, occupational therapy assistant, was named Employee of the Month for June at Lake Wales Medical Center. Abdul has worked at the hospital since 2014.

Lake Wales Medical Center presented its second quarter 2017 employee awards. Social worker Karey Lewis was Employee of the Quarter; Lori McKinney who works in the emergency room, was Manager of the Quarter, and Joan Hartshorn, who works in the gift shop, was Volunteer of the Quarter.

LAKELAND REGIONAL HEALTH

Dr. Cristina Cuevas-Korensky has joined Lakeland Regional Health as a hospitalist. Board certified by the American Board of Internal Medicine, Cuevas-Korensky received her Doctor of Medicine degree from Universidad de Salamanca School of Medicine in Spain, completed her residency in Internal Medicine at Western Reserve Care System in Youngstown, Ohio and her fellowship in Critical Care Medicine at Mount Carmel Hospital and Wayne State University in Detroit. She most recently served as a hospitalist at Florida Hospital Flagler and is fluent in English and Spanish.

Dr. John F. Hower Jr. has rejoined Lakeland Regional Health as Medical Director of its Wound Care and Hyperbaric Medicine Center at the Grasslands Campus, 3030 Harden Blvd., Lakeland. Board certified by the American Board of Surgery, Hower received his Doctor of Medicine degree at Tulane University School of Medicine in New Orleans after earning a Doctor of Philosphy degree in Physical Chemistry from Duke University in Durham, N.C., completed his residency in General Surger at Tulane University Affiliated Hospitals in Louisiana and completed his fellowship in Vascular Surgery at Touro Infirmary in New Orleans and East Jefferson Hospital in Metairie, La. He has had an affiliation with Lakeland Regional Health for more than 17 years, serving as a part-time and full-time trauma and general surgeon and a vascular surgeon.

Dr. Erjola Balliu has joined Lakeland Regional Health as an Endocrinologist and Pediatric Endocrinologist at the Pablo Campus, 130 Pablo St., Lakeland. Board certified by the American Board of Pediatrics and American Board of Internal Medicine, Balliu received her Doctor of Medicine degree from Ross University School of Medicine in the Dominican Republic, completed her fellowship in Adult and Pediatric Endocrinology and her internship and residency in the Department of Internal Medicine and Pediatrics at Stony Brook University Hospital in New York.

THE VILLA AT CARPENTERS

Matthew Thompson, Director of Health and Financial Services at The Villa at Carpenters in Lakeland was named the 2017 Assisted Living Facility Administrator of the Year by the Florida Health Care Association. Thompson has led his team to several awards including the American Health Care Association's Bronze and Silver National Quality Awards and recently earned his master's degree in Aging Services.

WATSON CLINIC

Rene Connors, reception team leader at the Watson Clinic Physical Therapy & Sports Medicine location in south Lakeland, was named the July recipient of Watson Clinic's Program for Employee Excellence and Recognition award. Connors has been with the clinic for eight years.

Certified Advanced Registered Nurse Practitioner Patricia C. Bayshore has joined Watson Clinic, working alongside board certified family medicine specialists Drs. Benjamin Phen, M. Karina Solorzano-Klapprott and Richard F. Sweeney at the Bartow location, 2250 Osprey Blvd., Suite 100. Certified by the American Academy of Nurse Practitioners, Bayshore received her Bachelor of Science in Nursing degree from the University of South Florida and her Master of Science in Nursing degree from the University of Tampa. Her areas of expertise include comprehensive primary care services for adults and children, acute and chronic disease management, physical examinations, nutrition counseling, weight management and wellness services.

Doctor of Osteopathic Medicine Elaine C. Turcan has joined Watson Clinic at the south location, 1033 N. Parkway Frontage Road, Lakeland. Board certified by the American Board of Family Medicine, Turcan received her Doctor of Osteopathic Medicine degree from the University of Health Sciences College of Osteopathic Medicine in Kansas City, Mo., performed an internship in family medicine at Doctors' Hospital in Groves, Texas, and a residency in family medicine at Wyoming Valley Practice in Kingston, Pa. Her areas of expertise include preventative medicine and pediatric patient care.

Doctor of Osteopathic Medicine Kenneth J. Stroub has joined Watson Clinic in Urgent Care at the main facility, 1600 Lakeland Hills Blvd., Lakeland. Board certified by the American Osteopathic Board of Family Physicians and a member of the American Osteopathic Association and American College of Osteopathic Family Physicians, Stroub received his Doctor of Osteopathic Medicine degree from Midwestern University/Chicago College of Osteopathic Medicine in Downers Grove, Ill., and performed a rotating internship at Muskegon General Hospital in Muskegon, Mich. and a Family Practice residency at Mercy General Hospital System in Muskegon.

Certified Advanced Registered Nurse Practitioner Caitlyn S. Bierly has joined Watson Clinic in the Urology department working alongside Dr. Gaines W. Hammond at the main clinic, 1600 Lakeland Hills Blvd., Lakeland. A member of the American Nurses Association, Florida Nurses Association and American Academy of Nurse Practitioners, Bierly received her Associate of Science in Nursing and Bachelor of Science in Nursing degrees from Polk State College and her Master of Science in Nursing degree from the University of Central Florida College of Nursing in Orlando. Her areas of expertise include general urology services and pre-operative/post-operative surgical care.

Dr. Megan B. Luciano has joined Watson Clinic in the OB-GYN department at the Bella Vista Building, 1755 N. Florida Ave., Lakeland. A member of the American College of Obstetricians and Gynecologists, Luciano received her medical degree from Marshall University/Joan C. Edwards School in Medicine in Huntington, W.Va., and completed her internship and residency in Obstetrics & Gynecology at Orlando Health Winnie Palmer Hospital for Women & Babies in Orlando.

- Send Medical People items to features@theledger.com.

Continued here:
Polk County people in medicine (September 5) - The Ledger - The Ledger

Read More...

VET CONNECTION: Flea season is upon us – The Salem News

September 7th, 2017 11:44 pm

This week a dying cat was brought into our hospital. She was about 10 years old, owned by a couple that had never taken her to the vet before. She was dehydrated and extremely pale, lying curled up on her side, unresponsive and breathing very shallow breaths, and her temperature was very low. The gentleman said to his wife, "Dont worry the vet will save her." Unfortunately we could not. Tears were shed. She had to be humanely euthanized. It was heartbreaking.

The saddest part about this cats death is that it was most likely preventable. This kitty was crawling with fleas. After she died, fleas were jumping off her like sailors off a sinking ship. They knew her lifeblood and their next meal was not flowing anymore. We had to perform an emergency flea clean up to prevent the hospital from becoming infested.

Fleas infest and bite mammals to obtain a blood meal. They defecate flea dirt," which looks like black coffee grounds all over the skin. Since one female flea lays 2,000 eggs and the flea eggs hatch in less than two weeks, you can have millions of fleas infesting a home by the end of the summer. The fleas living outside die in the frost that usually occurs in October, but indoors fleas live on. Fleas will usually parasitize your pets first. If the animal leaves the household they will then start biting humans. If you have flea bites you will notice little red itchy bumps usually around your legs and ankles, but they could be anywhere on your body if fleas are in your bed.

Fleas may transmit a few diseases to people and animals. Fleas carry tapeworm larvae. If a pet chewing its fur ingests a flea, it will get tapeworms. Fleas also transmit disease through biting. Bubonic plague, which is the bacteria Yersinia pestis, can be transmitted to pets and humans via a flea bite.

Cat scratch fever, or Bartonella henselae, is transmitted when a flea bites a cat. Some cats will have symptoms of inflammation at the back of their mouths or inflamed eyes and severe skin lesions. Many cats exhibit no symptoms but the bug can be found in their hearts, lymph nodes, kidneys and liver. Cats can in turn infect their owners with cat scratch fever via scratches, sometimes while exhibiting absolutely no sign of infection. People can develop severe skin lesions.

The best way to prevent these diseases is to keep your cat or dog parasite free. We no longer prevent or treat fleas with baths and dips. Topical and oral medications are used to fight fleas these days.

There are some flea and tick topical products sold in pet stores that are 30-year-old technology and are very ineffective. Other flea and tick products have the active ingredient fipronil, but do not have the chemical that allows that flea preventative to be carried transdermally into the fat layer throughout the body. This makes them much less effective. There are products on the shelf that can cause cats and small dogs to have severe reactions and seizures. Consult your veterinarian about which flea and tick preventative she recommends. Your veterinarian will recommend a safe product based on your individual pets lifestyle.

Purchasing a quality flea product from your veterinarian is often less expensive per dose than the same products from the big-box stores. The complimentary doses and the large coupon savings offered only by your veterinarian make the pricing very competitive.

If you already use flea preventative medicine, it is almost unimaginable that fleas could cause a cat to die. I have rarely seen that in my practice life and I hope to never see it again. Your veterinarian is dedicated to preventing disease from entering your household. That is why the veterinary hospital team discusses flea medication during your pets wellness appointment.

Dr. Elizabeth Bradt is a veterinarian and owner of a veterinary hospital on the North Shore. Email your pet questions to docliz@creaturehealth.com, with "Vet Connection" in the subject line.

||||

Read this article:
VET CONNECTION: Flea season is upon us - The Salem News

Read More...

Don’t let your pets fall for ticks this season – WTOP

September 7th, 2017 11:44 pm

Sponsored by Rocky Gorge Animal Hospital

By Dr. Steven Wolchinsky

With the onset of cooler weather, you may be tempted to start dropping your guard against ticks, but did you know that the late summer and early autumn is the peak time for these pesky parasites!

While you mostly find ticks in tall grass and woodlands, they also lurk about in the leaves your pets love to play in. They wait for an animal or human to brush past them so that they can jump and feed. They attach using their mouthparts and will feed on blood from their host for several days before finally dropping off.

Ticks can be transferred from pets coming into the household from outdoors and can even be transferred to humans. Ticks can spread diseases, including Lyme disease, which is a bacterial infection that can affect humans, dogs, cats and other mammals. Ticks from other areas have migrated to the mid-Atlantic and we are now commonly seeing other tick borne diseases such as Ehrlichiosis and Anaplasmosis, both bacterial infections that can affect pets and humans alike.

How do you know if your pet has ticks? Ticks are often visible to the naked eye, so its a good idea to check your pet regularly if you live in an area where ticks are prevalent, especially if they spend a lot of time outside. Run your hands carefully over your pet every time they come inside, and especially check inside and around the ears, head and feet.

If you believe your pet has ticks, schedule an appointment with your veterinarian as soon as possible so that they can remove the parasite. And remember prevention is key, so talk to your veterinarian today about the best preventative medicine to keep all your pets safe this fall.

More here:
Don't let your pets fall for ticks this season - WTOP

Read More...

Western Montana wildfire smoke continues to pose health risks – KTVH

September 7th, 2017 11:44 pm

MISSOULA Fires burning across the state continue to blanket Western Montana under athick layer of smoke, smoke that many of us are breathing in on a daily basis.

The air quality in Western Montana hasnt been clean for quite some time.There are between35 and 250 smoke particulates per cubic centimeter of air and when you breathe in thatcontaminated air, those particulates settle in the lungs.

So these irritants can settle in there and people that have baseline lung disease can be more at risk for problems from that, said Dr. Kristin Anderson, who practices family and preventative medicine.

Those problems range in severity, you may get a sore throat or worsening asthma, but some problemscould warrant immediate medical attention.

Chest heaviness is a pretty specific symptom, and thats one that doctors take very seriously, so obviously if you are feeling chest heaviness, its something that new to you or worsening, worse with activity, you need to be examined immediately, Dr. Anderson said.

Doctors advise people to avoid the outdoors as often as possible in order to help save your lungs.

This isnt the time to go and do some activities outside, certainly this isnt the day to work on your garden, but rather try to find some fun activities to do inside for the small ones and the young ones, Dr. Anderson said.

Missoula is a very active community, and people may not like the idea of spending the rest of the summer indoors, so they might be tempted to go to a hardware store and buy a paper mask. When air quality is bad, officials say paper masks really dont help.

Basic masks are probably not going to make much of a dent in what is going into your lungs from the smoke, Dr. Anderson said. They generally stop large particles, but not the smaller particles.

N95 industrial masks are recommended for those who are required to stay outside for

work, but Dr. Anderson said its best to stay indoors as much as possible.

As of Thursday morning, air quality had improved in Helena to Moderate.

For more information on air quality conditionsclick here.

MTNs Eric Clements

Read more here:
Western Montana wildfire smoke continues to pose health risks - KTVH

Read More...

What We Know About Medical Marijuana’s Effect On Heart Disease … – AlterNet

September 7th, 2017 11:44 pm

Photo Credit: Shutterstock.com

Almost everyone knows somebody that has been effected by heart diseasestatistics showthat coronary artery disease is the most fatal disease in the United States. To put this statistic into perspective, on an annual basis, one quarter of all deaths (or 600,000 yearly fatalities) in America are dueto heart disorders. For the most part, individuals contract heart disorders due to unhealthy life styles and bad habits including: fatty foods, smoking, drinking, and sloth.

The term heart diseaseis an umbrella phrase generally used to describe symptoms related to atherosclerosis, which arises with the gradual amassing of fats on the walls of arteries and veins.Over time, with a consistently unhealthy diet and lifestyle, these fatty deposits can eventually restrict blood flow in the arteries to the point of heart attack. However,there are a few other forms of heart diseaseincluding heart failure, arrhythmia, heart valve problems, and hypertension. While the causes of atherosclerosis (lifestyle, etc.) can also be attributed to these other heart maladies, there are a plethora of other sources for them, including stress and genetic disorders.

As with a majority of medical applications for cannabis, legitimate scientific research into the herbs potential as a medicine for victims of heart disease is in its infancybut findings thus far are quite profound. For the most part, studies into the potential use of cannabis as a medicine for heart disease are related to both CBD and abnormal cannabidiol. For starters,studies have shownthat CBD can be beneficial for heart disease victims as both a preventative and restorative medicine. Secondly,abnormal cannabidiolis potentially a wonder drug which can greatly help reduce the chances of heart attacks for atherosclerosis patients. Each of these fascinating compounds are worth exploring in more detail.

CBD has various theoretical medical applicationsfor heart disease. To begin with, CBD has been shown to cause blood vessels to vasodilate, improving blood flow and reducing blood pressure. Point being, CBD can possibly be utilized as a preventative medicine for heart attacks, as it has the potential to help blood vessels restrict and move more efficiently.Doctors also feelthat CBD can be used as an anti-arrhythmic which can reestablish normality in ones heart beat post heart attack.

Abnormal cannabidiolis a synthetically derived chemical which is related, on a molecular level, to the cannabinoids found within the marijuana plant. Also,abnormal cannibidiol sharesthe non-psychoactive properties of CBD, meaning that it does not get users high. TheBritish Journal of Pharmacology reportsthat the application of abnormal cannabidiol in lab rats led to the widening of blood veins and arteries by relaxing muscles on their walls. Point being,findings showthat abnormal cannabidiol, like CBD, can help lessen the chances of heart attacks by opening up blood flow within veins and arteries that would be otherwise restricted by atherosclerosis. It goes without saying that these findings warrant far more research into the potential uses of medical marijuana in relations to heart disease.

See the article here:
What We Know About Medical Marijuana's Effect On Heart Disease ... - AlterNet

Read More...

Dr. David Russell and Kirsten Pickard, ARNP, to join the UW Medicine Orcas Island Clinic – Islands’ Sounder

September 7th, 2017 11:44 pm

UW Medicine is pleased to announce that Dr. David Russell and Kirsten Pickard, ARNP, will be joining the UW Medicine Orcas Island Clinic effective November 1, 2017. Russell, who has been an Orcas Island resident since 2003, started the Orcas Island Family Medicine clinic in 2004 and is a primary care provider practicing family medicine. Pickard, who worked with Russell at the Family Medicine clinic, lives on Waldron Island and has been a full-time resident there for three years.

I look forward to working with UW Medicine to establish a primary care clinic that will provide compassionate and effective health care for the residents of Orcas Island, said Russell. I am also pleased that Kirsten will also be joining this practice.

As an ARNP, Pickard has a special interest in womens health and obstetrics as well as preventative health and end-of-life care. She is excited to continue her work on the island.

I could not be more excited than to have this opportunity to work with UW Medicine on my own professional and community goals, said Pickard. My goals are to ensure access to quality healthcare while providing that care to a diverse population.

Both Russell and Pickard will be working Monday through Friday and Pickard hopes to provide some Saturday coverage as well. The two providers will be joining Dr. Michael Alperin, who was just named Clinic Chief of both the UW Medicine Orcas Island Clinic and the UW Medicine Lopez Island Clinic.

More here:
Dr. David Russell and Kirsten Pickard, ARNP, to join the UW Medicine Orcas Island Clinic - Islands' Sounder

Read More...

Pig stem cells a new reality? – Independent Online

September 7th, 2017 11:44 pm

Researchers have found a way to transform ordinary cells from pigs into powerful stem cells in a move that may have implications for human health.

With these stem cells, they hope to modify porcine genes that are related to the immune system so that its organs may some day be used for people in need of transplants.

In an article published in the Journal of Molecular Cell Biology, the researchers from China described how they managed to re-programme ordinary cells taken from the ear and bone marrow of a 10-week-old pig using a virus.

"The cells changed and developed in the laboratory into colonies of embryonic-like stem cells," wrote the researchers, led by Xiao Lei, who heads the stem cell lab at the Shanghai Institute of Biochemistry and Cell Biology.

Embryonic stem cells are capable of developing into any type of cell in the body.

"The research could open the way to creating models for human genetic diseases, genetically engineering animals for organ transplants for humans, and for developing pigs that are resistant to diseases such as swine flu," they said.

The researchers also hope to use their discovery to improve pig farming.

Commenting on this latest development, Chris Mason, professor of Regenerative Medicine at the University College London, said it would help in the treatment of organ failure.

"This breakthrough to produce pig stem cells potentially reinvigorates the quest to grow humanised pig organs such as pancreases for diabetics and kidneys for chronic renal failure," said Mason, who was not involved in the Chinese study. (Reporting by Tan Ee Lyn; Editing by Jon Hemming) - Reuters

See original here:
Pig stem cells a new reality? - Independent Online

Read More...

Nanomedicine Research Journal

September 7th, 2017 11:43 pm

Nanomedicine Research Journal (Abbreviation: Nanomed Res J)

is an international, open access, peer-reviewed, electronic and print quarterly publication released by the Iranian Society of Nanomedicine (ISNM). Nanomedicine Research Journal publishes original research articles, review papers, mini review papers, case reports and short communications covering a wide range of field-specific and interdisciplinary theoretical and experimental results related to applications of nanoscience and nanotechnology in medicine including, but not limited to, diagnosis, treatment, monitoring, prediction and prevention of diseases, tissue engineering, nano bio-sensors, functionalized carriers and targeted drug delivery systems.

* Publication process of manuscripts submitted to Nanomed Res J is free of charge.

To see Acceptance timeline Please follow the link below:

Acceptance Timeline Diagram

About the publisher

Founded in 2011 by the leading ofSchool of Advanced Technologies in medicine (SATiM),Tehran University of Medical Sciences (TUMS) and Iran Nanotechnology Initiative Council, the Iranian Society of Nanomedicine (ISNM) attempts to promote and develop medical nanotechnology in Iran. For more information about the publisher, please visit us at http://isnm.ir/en/.

Go here to read the rest:
Nanomedicine Research Journal

Read More...

Subaction showcomments propecia start from online – My propecia experience – Propecia merck price – Black Hills Today

September 6th, 2017 7:51 pm

Condo 2B/2B UTC Sarasota Condo 2B/2B UTC Sarasota For Sale Are you a shopping fanatic. One of Floridas best shopping malls happens to be very close to this wonderful condo for sale. UTC features several fine restaurants like Capital Grill, Cheese Cake Factory, and Tuscan Brio. Macys and Dillards featured on both ends....Read More

Sarasota Condo For Sale FOR SALE 2B/2B CONDO SARASOTA, FLORIDA 3423 Beekman Place Road, Sarasota, FL 43 WEST BEEKMAN PLACE OFF LOCKWOOD RIDGE (MOVE IN READY) 2Bed/2Bath (w/ Den & Garage) 1,250 sq. ft. Condo located in a quiet subdivision within Beekman Place Community off Lockwood Ridge Rd. Updated kitchen, wood...Read More

Sarasota Carpet Repair Recommendation and Rating Carpet installers Dean and Scott are extremely professional (Five Stars) and very fast carpet installers Dean and Scott are very nice. Ive used them twice and always on time and very good price. I did their picture to share with everyone! Call them, they always...Read More

Link:
Subaction showcomments propecia start from online - My propecia experience - Propecia merck price - Black Hills Today

Read More...

Profit Maximization is Easy: Invest in Violence – Pressenza International Press Agency

September 6th, 2017 7:51 pm

For those of us committed to systematically reducing and, one day, ending human violence, it is vital to understand what is causing and driving it so that effective strategies can be developed for dealing with violence in its myriad contexts. For an understanding of the fundamental cause of violence, see Why Violence?

However, while we can tackle violence at its source by each of us making and implementing My Promise to Children, the widespread violence in our world is driven by just one factor: fear or, more accurately, terror. And I am not talking about jihadist terror or even the terror caused by US warmaking. Let me explain, starting from the beginning.

The person who is fearless has no use for violence and has no trouble achieving their goals, including their own defence, without it. But fearlessness is a state that few humans would claim. Hence violence is rampant.

Moreover, once someone is afraid, they will be less likely to perceive the truth behind the delusions with which they are presented. They will also be less able to access and rely on other mental functions, such as conscience and intelligence, to decide their course of action in any context. Worse still, the range of their possible responses to perceived threats will be extremely limited. And they will be more easily mobilised to support or even participate in violence, in the delusional belief that this will make them safe.

For reasons such as these, it is useful for political and corporate elites to keep us in a state of fear: social control is much easier in this context. But so is profit maximization. And the most profitable enterprise on the planet is violence. In essence then: more violence leads to more fear making it easier to gain greater social control to inflict more violence. And starting early, by terrorizing children, is the most efficient way to initiate and maintain this cycle. See Why Violence? and Fearless Psychology and Fearful Psychology: Principles and Practice.

So, for example, if you think the massive number of police killings of innocent civilians in the United States see Killed by Police and The Counted: People killed by police in the US is a problem, you are not considering it from the perspective of maintaining elite social control and maximizing corporate profit. Police killings of innocent civilians is just one (necessary) part of the formula for maintaining control and maximising profit.

This is because if you want to make a lot of money in this world, then killing or exploiting fellow human beings and destroying the natural world are the three most lucrative business enterprises on the planet. And we are now very good at it, as the record shows, with the planetary death toll from violence and exploitation now well over 100,000 human beings each day, 200 species driven to extinction each day and ecological destruction so advanced that the end of all life (not just human life) on Earth is postulated to occur within decades, if not sooner, depending on the scenario. See, for example, The End of Being: Abrupt Climate Change One of Many Ecological Crises Threatening to Collapse the Biosphere.

So what forms does this violence take? Here is a daily accounting.

Corporate capitalist control of national economies, held in place by military violence, kills vast numbers of people (nearly one million each week) by starving them to death in Africa, Asia and Central/South America. This is because this economic system is designed and managed to allocate resources for military weapons and corporate profits for the wealthy, instead of resources for living.

Wars kill, wound and incapacitate a substantial number of civilians, mostly women and children, as do genocidal assaults, on a daily basis, in countries all over the planet. Wars also kill some soldiers and mercenaries.

Apart from those people we kill every day, we sell many women and children into sexual slavery, we kidnap children to terrorise them into becoming child soldiers and force men, women and children to work as slave labourers, in horrific conditions, in fields and factories (and buy the cheap products of their exploited labour as our latest bargain).

We condemn millions of people to live in poverty, homelessness and misery, even in industrialized countries where the refugees of western-instigated wars and climate-destroying policies are often treated with contempt. We cause many children to be born with grotesque genetic deformities because we use horrific weapons, like those with depleted uranium, on their parents. We also inflict violence on women and children in many other forms, ranging from ordinary domestic violence to genital mutilation.

We ensnare and imprison vast numbers of people in the police-legal-prison complex. See The Rule of Law: Unjust and Violent. We pay the pharmaceutical industry and its handmaiden, psychiatry, to destroy our minds with drugs and electro-shocking. See Defeating the Violence of Psychiatry. We imprison vast numbers of children in school in the delusional belief that this is good for them. See Do We Want School or Education? And we kill or otherwise exploit animals, mostly for human consumption, in numbers so vast the death toll is probably beyond calculation.

We also engage in an endless assault on the Earths biosphere. Apart from the phenomenal damage done to the environment and climate by military violence: we emit gases and pollutants to heat and destroy the atmosphere and destroy its oxygen content. We cut down and burn rainforests. We cut down mangroves and woodlands and pave grasslands. We poison the soil with herbicides and pesticides. We pollute the waterways and oceans with everything from carbon and nitrogenous fertilizers to plastic, as well as the radioactive contamination from Fukushima. And delude ourselves that our token gestures to remedy this destruction constitutes conservation.

So if you are seeking work, whether as a recent graduate or long-term unemployed person, then the most readily available form of work, where you will undoubtedly be exploited as well, is a government bureaucracy or large corporation that inflicts violence on life itself. Whether it is the military, the police, legal or prison system, a weapons, fossil fuel, banking, pharmaceutical, media, mining, agricultural, logging, food or water corporation, a farm that exploits animals or even a retail outlet that sells poisonous, processed and often genetically-mutilated substances under the label food see Defeating the Violence in Our Food and Medicine you will have many options to help add to the profits of those corporations and government services that exist to inflict violence on you, your family and every other living being that shares this biosphere.

Tragically, genuinely ethical employment is a rarity because most industries, even those that seem benign like the education, finance, information technology and electronics industries, usually end up providing skilled personnel, finance, services or components that are used to inflict violence. And other industries such as those in insurance and superannuation, like the corporate banks, usually invest in violence (such as the military and fossil fuel industries): it is the most profitable.

So while many government bureaucracies and corporate industries exist to inflict violence, in one form or another, they can only do so because we are too scared to insist on seeking out ethical employment. In the end, we will take a job as a teacher, corporate journalist or pharmaceutical drug pusher, serve junk food, work in a bank, join the police or military, work in the legal system, assemble a weapons component rather than ask ourselves the frightening questions Is this nonviolent? Is this ethical? Does it enhance life?

And yes, I know about structural violence and the way it limits options and opportunities for those of particular classes, races, genders. But if ordinary people like us dont consider moral issues and make moral choices, why should governments and corporations?

Moral choices? you might ask in confusion. In this day and age? Well, it might seem old-fashioned but, in fact, while most of us have been drawn along by the events in our life to make choices based on such considerations as self-interest, personal gain and financial security, there is a deeper path. Remember Gandhi? True morality consists not in following the beaten track, but in finding the true path for ourselves, and fearlessly following it.

Strange words they no doubt sound in this world where our attention is endlessly taken by all of those high-tech devices. But Gandhis words remind us that there is something deeper in life that the violence we have suffered throughout our lives has taken from us. The courage to be ourselves and to seek our own unique destiny.

Do you have this courage? To be yourself, rather than a cog in someone elses machine? To refuse to submit to the violence that surrounds and overwhelms us on a daily basis?

If you are inclined to ponder these questions, you might also consider making moral choices that work systematically to end the violence in our world: consider participating in The Flame Tree Project to Save Life on Earth, signing the online pledge of The Peoples Charter to Create a Nonviolent World and/or helping to develop and implement an effective strategy to resist one or the other of the many threats to our survival using the strategic framework explained in Nonviolent Campaign Strategy.

Of course, these choices arent for everyone. As Gandhi observed: Cowards can never be moral.

See the rest here:
Profit Maximization is Easy: Invest in Violence - Pressenza International Press Agency

Read More...

UCLA receives $8.4 million NIH grant to help liver transplant recipients stay healthier longer – UCLA Newsroom

September 6th, 2017 7:50 pm

UCLA has received an $8.4 million grant from the National Institutes of Health to research ways to help donated livers last longer and improve outcomes for transplant recipients.

The five-year grant is the fourth in a series from the NIH to the DumontUCLA Transplant Center to develop medications to prevent the body from rejecting a transplanted liver and help patients live longer, healthier lives. The grants have totaled more than$13million.

The initiative is headed by Dr. Jerzy Kupiec-Weglinski, the Paul I. Terasaki Chair in Surgery and vice chair of research at the Department of Surgery at the David Geffen School of Medicine at UCLA. The project brings together the expertise and experience of researchers from the UCLA departments of surgery, pathology and laboratory medicine, and microbiology, immunology and molecular genetics.

UCLA Health

Dr. Jerzy Kupiec-Weglinski

There are less than 10 program project grants in the country funded by the NIH that are related to organ transplantation, so this is a big deal, Kupiec-Weglinski said. Through this project, we believe we will develop novel therapeutic strategies that can be directly applied in transplant patients.

Around 6,000 liver transplant surgeries are performed every year in the U.S., and UCLAs liver transplant program was the nations fourth busiest last year, according to the United Network for Organ Sharing. UCLA doctors performed 161 liver transplants in 2016. The UCLA division of liver and pancreas transplantation is headed by Dr. Ronald Busuttil and is a part of the department of surgery.

About 90 percent of people who undergo liver transplants at UCLA survive at least one year after their surgeries, which is the mark of success for the procedure.

However, the long-term outcomes are not so great for many recipients, regardless of where they receive their transplant, Kupiec-Weglinski said. Graft rejection and a lack of donor organs continue to be major problems for organ recipients.

On average, transplanted livers remain viable for 15 years, so recipients who live that long after their transplant must eventually return to the waiting list for a new organ. Organ recipients also have a higher risk of opportunistic infections because they must remain on immune-suppressing medications for life in order to prevent organ rejection.

This project addresses two of the major problems in transplantation worldwide: the decreasing quality of donor organs and a widening disparity between the increasing numbers of potential transplant recipients and inadequate donor organ supply, Kupiec-Weglinski said.

Learn more about the immunity, inflammation, infection and transplantation research theme, or I3T, at UCLA.

Go here to read the rest:
UCLA receives $8.4 million NIH grant to help liver transplant recipients stay healthier longer - UCLA Newsroom

Read More...

Analyzing BioTelemetry (BEAT) and Signal Genetics (MGEN) – The Ledger Gazette

September 6th, 2017 7:50 pm

BioTelemetry (NASDAQ: BEAT) and Signal Genetics (NASDAQ:MGEN) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, analyst recommendations, valuation, profitability and risk.

Institutional and Insider Ownership

78.0% of BioTelemetry shares are held by institutional investors. Comparatively, 20.7% of Signal Genetics shares are held by institutional investors. 9.6% of BioTelemetry shares are held by insiders. Comparatively, 44.4% of Signal Genetics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Risk & Volatility

BioTelemetry has a beta of 0.73, indicating that its share price is 27% less volatile than the S&P 500. Comparatively, Signal Genetics has a beta of 1.96, indicating that its share price is 96% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent ratings and target prices for BioTelemetry and Signal Genetics, as provided by MarketBeat.com.

BioTelemetry currently has a consensus price target of $45.75, indicating a potential upside of 21.19%. Signal Genetics has a consensus price target of $23.00, indicating a potential upside of 156.70%. Given Signal Genetics higher possible upside, analysts clearly believe Signal Genetics is more favorable than BioTelemetry.

Valuation and Earnings

This table compares BioTelemetry and Signal Genetics revenue, earnings per share (EPS) and valuation.

BioTelemetry has higher revenue and earnings than Signal Genetics.

Profitability

This table compares BioTelemetry and Signal Genetics net margins, return on equity and return on assets.

Summary

BioTelemetry beats Signal Genetics on 7 of the 11 factors compared between the two stocks.

BioTelemetry Company Profile

BioTelemetry, Inc. (BioTelemetry), formerly CardioNet, Inc., provides cardiac monitoring services, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. The Company operates in three segments: patient services, product and research services. The patient services business segments principal focus is on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders, through its core Mobile Cardiac Outpatient Telemetry(MCOT), event and Holter services in a healthcare setting. The product business segment focuses on the development, manufacturing, testing and marketing of medical devices to medical companies, clinics and hospitals. The Companys research services focuses on providing cardiac safety monitoring services for drug and medical treatment trials in a research environment. In August 2012, the Company completed the acquisition of Cardiocore Lab, Inc. (Cardiocore).

Signal Genetics Company Profile

Signal Genetics, Inc. is a commercial stage, molecular genetic diagnostic company. The Company is focused on providing diagnostic services that help physicians to make decisions concerning the care of cancer patients. The Companys diagnostic service is the Myeloma Prognostic Risk Signature (MyPRS) test. The MyPRS test is a microarray-based gene expression profile (GEP), assay that measures the expression level of specific genes and groups of genes that are designed to predict an individuals long-term clinical outcome/prognosis, giving a basis for personalized treatment options. The Companys MyPRS test provides a whole-genomic expression profile of a patients multiple myeloma (MM). The Company offers MyPRS test in its laboratory located in Little Rock, Arkansas. The Company is licensed to sell its test in all 50 states.

Receive News & Ratings for BioTelemetry Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioTelemetry Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Original post:
Analyzing BioTelemetry (BEAT) and Signal Genetics (MGEN) - The Ledger Gazette

Read More...

The 2 Major Catalysts Behind Myriad Genetics, Inc.’s 26% Gain in August – Motley Fool

September 6th, 2017 7:50 pm

What happened

Shares of Myriad Genetics (NASDAQ:MYGN), a leading developer of molecular diagnostic tests, surged by 26% during the month of August, according to data from S&P Global Market Intelligence. Why the sudden surge? The bulk of the gains look traceable to the company's fourth-quarter and full-year earnings release on Aug. 8, as well as positive insurance coverage decisions made on a key diagnostic product mid-month.

The rally really began for Myriad Genetics following the release of its fourth-quarter report. During Q4, Myriad wound up generating $200.5 million in sales, an 8% year-over-year improvement, largely helped by growth in its GeneSight test.Despite the jump in sales, its adjusted profit fell by 17% to $0.30 per share. Nevertheless, Myriad wound up topping Wall Street's sales and profit projections for the fourth quarter. This beat, coupled with growth from newer diagnostic products, which have helped offset competitive weaknesses in its hereditary cancer testing franchise (e.g., BRCA gene tests), clearly have investors upbeat about Myriad's prospects.

Image source: Getty Images.

The other catalyst driving big gains in August was favorable insurer coverage decisions for EndoPredict, a next-generation prognostic test that helps physicians determine a best course of care for patients with breast cancer. Myriad wound up announcing that Palmetto GBA, the Medicare contractor that oversees the MoIDx (Molecular Diagnostics) program, and Anthem, the second-largest insurer nationally, have decided to cover EndoPredict.Following the implementation of these decisions, Myriad will be able to cover more than 90% of breast cancer patients, which is pretty impressive considering EndoPredict was launched less than six months ago.

In a world of personalized medicine, Myriad Genetics continues to lead the charge. Unfortunately, this is also an increasingly crowded space that tends to rely on healthy reimbursements from Medicare and Medicaid. With the Trump administration looking to cut long-term payouts to both programs, it leaves Myriad's future somewhat cloudy.

By a similar token, the company has also seen price erosion from competition in its hereditary cancer segment, from which it derives about three-quarters of its sales. However, growth from new products, compounded with volume growth in hereditary cancer testing, even at a lower margin, could still fuel substantial sales and profit improvements in the coming years.

So, what's an investor to do? I'd suggest that modest optimism seems fair at these levels. It's probably going to take a few more years before sales in Myriad's core operating segment level off, but at the same time it should be able to continue to grow its newly launched diagnostic products. Once the company has a more balanced revenue stream, it should be able to throttle back a bit on its operating expenses and allow its operating margin to soar. Patient investors with at least a five-year time horizon should do just fine.

Sean Williams has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Excerpt from:
The 2 Major Catalysts Behind Myriad Genetics, Inc.'s 26% Gain in August - Motley Fool

Read More...

College of Veterinary Medicine searches for new dean – Kansas State Collegian

September 6th, 2017 7:50 pm

After two years as dean of the College of Veterinary Medicine, Tammy Beckham has resigned. Beckham accepted an offer to work for the Department of Defense in their Cooperative Biological Engagement Program, according to an email from Barbara Lutjemeier, executive assistant to the dean of the College of Veterinary Medicine.

The process of finding a new dean started right away, with executive associate dean Bonnie Rush appointed as acting dean. Currently, the college is undergoing the first stage of the dean replacement process, searching for an interim dean.

The search for interim dean is conducted within the college, and the timeline is short. Applications for interim dean were due Aug. 30, 2017. The applications are currently being considered.

Kansas States College of Veterinary Medicine is nationally renowned for its prestige. The search for a permanent dean will extend beyond the bounds of the university and be conducted nationally in order to find the best candidate for the position.

Applicants must be a doctor of veterinary medicine, and they must have some collegiate experience making them suitable for the position. The dean of veterinary medicine is in charge of overseeing activity in the departments, representing the college and acting as the point person for fundraising.

The members of the interim dean search committee were chosen by April Mason, provost and senior vice president of K-State. Mason selected professors from the College of Veterinary Medicine, as well as professors from other colleges, a student representative and a representative from the American Veterinary Medical Association.

Brian Niehoff, chair of the search committee, is also the associate provost for institutional effectiveness. Niehoff has been the chair for three previous interim dean searches.

There are only around thirty veterinary colleges in the nation, Niehoff said. The relationship we have with rural and urban communities is very important.

The College of Veterinary Medicine conducts research on numerous topics related to Kansas agriculture in addition to other research ventures, like studying cancer.

When asked about the timeframe for permanently replacing the dean, Niehoff said the acting dean can only operate for about a month, so the interim dean will be expected to be announced in late September or early October. Niehoff also said he hopes there will be a new permanent dean by the beginning of the 2018-2019 school year.

The rest is here:
College of Veterinary Medicine searches for new dean - Kansas State Collegian

Read More...

Veterinarian told you to stop bringing your pet in? It’s probably your fault – Miami Herald

September 6th, 2017 7:50 pm

Q: My veterinarian sent me a letter saying that she would not see my pet anymore. Is this legal?

A: As long as shes not withholding your pets medical records, divorce is perfectly legal in medicine, whether in human healthcare or veterinary medicine. But lets be clear: In a veterinary context divorce is never about the pet. Its always about the human.

When clients add stress to our lives above and beyond what we consider fair, veterinarians sometimes initiate divorce proceedings. This message typically arrives in the guise of a nice letter explaining that were sorry to see your pet go.

Though it may seem harsh, you can bet that if youre receiving that kind of notice youve done something to deserve it. After all, we feel for your pet. And we dont reject paying customers for no good reason. Here are a few reasons why you mightve been cut off:

Behavior problems. Sometimes a pets misbehavior leads us to part ways. In my experience, however, its usually because of the owners approach to the pets unruliness. This is especially true if the owners permissiveness and denial of the problem lead to safety issues.

Financial issues. Some owners will dispute their bills after theyve agreed to them. Though we typically try to work it out, its not always doable.

Unfair demands. Chances are youve met people who can be demanding about their pets. We respect that they care so much for their pets, but when their demands repeatedly interfere with the normal course of our work, we sometimes have to part ways.

Unrealistic expectations. Sometimes owners expect their pet to be healed immediately. Though we work hard to manage expectations, some owners remain convinced that a cure should occur instantaneously and can even become irate should we fail to meet these lofty goals.

Shady behavior. Every once in a while well be confronted with pet people who will ask us to engage in fraudulent behavior on their behalf (on an insurance form or in a government document, for example). These clients are often terminated.

Verbal abuse. If youre having a bad day I can put up with a lot. But make my receptionist cry and youre getting one of those letters. As to why you received one I cannot say, but if youre unsure, Im sure your veterinarian will be happy to explain.

Dr. Patty Khuly has a veterinary practice at Sunset Animal Clinic in South Miami. Her website is drpattykhuly.com.

Send questions to khulyp@bellsouth.net.

See the rest here:
Veterinarian told you to stop bringing your pet in? It's probably your fault - Miami Herald

Read More...

The Impossible Burger wouldn’t be possible without genetic engineering – Salon

September 6th, 2017 7:49 pm

This article originally appeared on Grist

The Impossible Burger has had a charmed honeymoon period. Crowds offoodies surged into fancy eateriesto try it.Environmentalistsandanimal rights activistsswooned. So did investors: Impossible Foodsbrought in $75 millionduring its latest investment round.

Now the backlash is here. The activist organizationsFriends of the Earthand theETC Groupdug up documents which they claim show that Impossible Foods ignored FDA warnings about safety and they handed them over to the New York Times.

Theensuing storydepicted Impossible Foods as a culinary version of Uber disrupting so rapidly that its running headlong into government regulators. In reality, Impossible Foods has behaved like a pedestrian food company, working hand in hand with the FDA and following a well-worn path to comply with an arcane set of rules.

So why isnt this story a nothingburger?

In a word: GMOs. You see, soy leghemoglobin, or SLH, the key ingredient that makes the Impossible Burger uniquely meaty, is churned out by genetically modified yeast. This is a protein produced with genetic engineering; its a new food ingredient, Dana Perls, senior food and technology campaigner at Friends of the Earth, told me when I asked why theyd singled out Impossible Foods.

The company has never exactly hidden the fact that they used genetic engineering, but they havent put it front and center either. You have to dig into theirfrequently asked questionsto catch that detail and thats a recent edit, according to Perls. When I first looked at the Impossible Foods website, maybe back in March, there was no mention of genetic engineering, she said.(An Impossible Foods spokesperson disputed Perlss claim, saying the FAQ has included references to genetic engineering for at least a year, since before the burgers launch in restaurants. But areview of cached webpagessuggests the references were added in June.*)

By tiptoeing around this issue, Impossible Foods set themselves up for a takedown by anti-GMO campaigners. These groups monitor new applications of genetic engineering, watch for potentially incriminating evidence, then work with journalists to publicize it. In 2014, Ecover, a green cleaning company,announced it was using oils made by algae as part of its pledge to remove palm oil a major driver of deforestation from its products. When Friends of the Earth and the ETC Groupfigured out the algae was genetically engineered, they pingedthe same Times writer. Ecover quickly went back to palm oil.

WhenI asked Impossible Foods founder Pat Brownabout the GMO question, he said he didnt think that battle was theirs to fight. After all, the SLH may be produced by transgenic yeast, but it isnt a GMO itself. He also pointed out that this isnt unusual:nearly all cheese contains a GMO-produced enzyme.

But now, Friends of the Earth and the ETC Group have brought their battle to Impossible Foods doorstep. (In ablisteringseriesofresponsesto the New York Times article, the company charged it was chock full of factual errors and misrepresentations and was instigated by an extremist anti-science group.)The FDA documents handed over to the Timesinclude worrying sentences like this one: FDA stated that the current arguments at hand, individually and collectively, were not enough to establish the safety of SLH for consumption.

If FDA officials say your company hasnt done enough to convince them that a new ingredient is safe, arent you supposed to stop selling it?

Not according toa risk expert at Arizona State Universitywho reviewed the documents released by activists. There are no indications that they should have pulled this off the market, Andrew Maynard told me.

Thats just not how the food safety review process works, said Gary Yingling, a former FDA official now helping Impossible Foods navigate the bureaucracy. In the United States, its up to the companies themselves to determine if an ingredient is safe. (Not everyone likes that systemorthinks the FDA is doing enoughto protect public safety, but it is the law.)

Impossible worked with a group of experts at universities who decided in 2014 that their burger was safe. SLH, it turns out, grows naturally in the roots of soy plants, and the proteins in the burger look a lot like animal proteins a good indicator of safety.

Impossible could have stopped there: Companies, however, can ask the government to weigh in on their research. Sometimes, the FDA asks for more information, which is what happened with Impossible Foods. Its not unusual for the FDA to determine it cant establish the safety of a new ingredient its happened more than 100 times, with substances like Ginkgo biloba, gum arabic, and Spirulina. The FDA has called for more information in about one in every seven of the ingredients companies have asked it to review.

In the case of SLH, the FDA suggested more tests, including rat-feeding trials. Impossible Foods has finished these tests, and academics who have studied the new data confirmed that its generally recognized as safe. Next, Impossible Foods will bring the new evidence back to the FDA, Yingling said.

The criticism raised in this case is really criticism of a system that allows companies to decide for themselves if a new ingredient is OK to add to our food.

If a company decides something is safe, they can go ahead and do it, said Maynard, the risk expert. So thats a weakness in the system. On the other hand, you can argue that once you start this process with the FDA, they have smart scientists who ask tough questions. You can see in those documents that the level of due diligence that a company has to go through is really pretty deep. You really want to make sure that you have a system that doesnt inhibit innovation, but captures as much potentially harmful things as possible.

Each new innovation creates the potential for new hazards. We can block some of those hazards by taking precautions. But how high should we put the precautionary bar?

Impossible Burger could indeed pose some unknown hazard. We just have to weigh that against the known hazards of the present foodborne diseases in meat, greenhouse gases from animal production, the development of antibiotic resistant bacteria in farms, and animal suffering. These are problems which Impossible Foods is trying to solve.

There are other companies trying to solve these problems. (Friends of the Earthnotesthat the success of non-animal burgers, like the non-GMO Beyond Burger, demonstrates that plant-based animal substitutes can succeed without resorting to genetic engineering.) But its not yet clear that any of these companies including Impossible Foods will be successful in just generating a profit, let alone in replacing the global meat industry. No one knows which startups will pan out. And well probably need to try and discard lots of new things as we shift to a sustainable path.

Trying new things can be risky. Not trying new things and staying on our current trajectory is even more risky.

*This story has been updated to include a response from Impossible Foods about when references to genetic engineering first appeared in its FAQ, and to add information about the FDAs food safety review process.

Read more from the original source:
The Impossible Burger wouldn't be possible without genetic engineering - Salon

Read More...

Climate change will cause food shortages. We should use genetic engineering to prevent them – Salon

September 6th, 2017 7:49 pm

This article originally appeared on Massive.

Even small changes in temperature can have massive impacts on crop productivity. In the United States, a single degree of warming is expected to decrease corn yield by 10 percent. Worldwide, one degree of warming is expected to decrease crop productivity by 3-7 percent. Making matters worse, at the same time as crop yields are expected to decrease, the global population will continue to rise. If we do nothing to slow the effects of climate change, we risk a global food shortage that will affect us all.

Deep cuts to greenhouse gas emissions could do a lot to stave off disaster. But many researchers predict that even if we stopped all emissions tomorrow, wed still experience some degree of future warming due to past emissions. So, even if we prevent additional damage, well still have to adapt to the changes in climate that are already underway.

If we want to feed our growing population, well have to tackle the problem of adapting agriculture to climate change head-on. Right now, one of our best hopes for adapting to a warming climate is a controversial one: genetically engineering our crops to survive better in higher temperatures.

Genetic engineering, the process of directly modifying an organisms DNA, strikes many people as an arrogant, unsafe intrusion on the natural world. The debate over GMOs (genetically modified organisms) has raged for decades, with opponents arguing that our capacity to tinker with nature has outpaced our understanding of the risks.

Concerns about the safety and ethics of genetic engineering are absolutely valid, but we should also realize that, in some cases, our ethical intuition may lead us astray. If you have ever grown a tomato plant, and you live somewhere other than the Andean region of South America, you have selected a plant with mutations that allow it grow somewhere it wouldnt naturally do so. When we domesticated the tomato plant, we picked out mutant plants that were able to thrive in different areas of the globe. The difference between that process and genetic engineering is that scientists dont have to search for a rare mutant; they can create it themselves.

Speedier adaptation

CRISPR/Cas9 genome editing tools have made modifying DNA much easier. Using CRISPR/Cas9, scientists can create a DNA break in a specific place in the genome. They provide a strand of DNA that has a new sequence and the cell copies from that strand when it repairs the break, creating a genetic change.

Crops made using this technique are not, strictly speaking, GMOs, because they contain no foreign DNA. A wild tomato plant that was modified using CRISPR/Cas9 to be able to grow further north would be indistinguishable from the mutant plants that arose naturally, right down to the molecular level. And yet if engineers use genome editing to make that same change, it strikes many people as dangerous, even though the plants are completely identical.

Our food sources have already benefited from past forays into genetic engineering. Researchers past efforts were focused on creating crops that are resistant to pests and disease. This is an important part of feeding the world we could feed 8.5 percent of all the people on Earth with the crops lost to fungal pathogens alone. Climate change is making this problem worse: as warmer temperatures have spread toward the poles, so has disease.

But disease isnt the sole consequence of climate change: the overall yield of food will likely drop because the areas where crops grow will no longer have the right weather for them to thrive.

Expanding crop-growing regions

One solution to this problem is to move heat-sensitive crops closer to the poles. But its not that simple: the seasonal cue that tells many plants when to flower is day length, and day length depends on latitude. That means you cant take a plant that requires short days, move it further north, and expect it to produce fruit, even if its at the right temperature.

Recently, researchers discovered the gene that represses flowering in tomato plants in response to long days. Its thanks to the variation in this gene that were able to grow tomatoes further from the equator. These researchers used CRISPR to show that disrupting this gene results in plants that flower rapidly, regardless of day length. That means that if we want crops to grow at different latitudes, we wont have to find a rare mutant. By zeroing in on the genes that control day-length-sensitive flowering, we can create those crops within months.

Increasing yields

And when it comes to boosting crop productivity, one option is to create plants that convert sunlight into food more efficiently. Thats the goal of the RIPE(Realizing Increased Photosynthetic Efficiency) project, an international group working to increase crop yield by improving photosynthesis through genetic engineering.

Surprisingly, photosynthesis isnt as efficient as it could be. Plants dont adapt as quickly as they could to transitions between sunlight and shade. When theres too much sunlight, plants protect themselves by releasing excess light as heat. But if a cloud passes in front of the sun, the protective mechanism lingers, which means less photosynthesis and lower yield. By speeding up the process of adaptation, RIPE scientists have shown that they can increase crop yield by 15 percent.

Although producing enough food to feed the world is crucial, genetic engineering isnt a cure-all. As long as we fail to confront the problems of war and unequal distribution of wealth, people will starve no matter how much food we produce. But adapting agriculture to climate change is unquestionably part of the equation, and genetic modification allows us to produce those changes quickly, easily, and safely.

Critiques of genetic engineering often focus on the most ethically questionable and unsettling research, but many scientists are doing work that could save the lives of millions. Keeping a closed mind risks demonizing a technology that may help us to survive.

Follow this link:
Climate change will cause food shortages. We should use genetic engineering to prevent them - Salon

Read More...

Fall armyworm threatens Nigerian crops; genetic engineering offers … – Genetic Literacy Project

September 6th, 2017 7:49 pm

Nigeria remains Africas largest [corn] producer, growing nearly 8 million tons annually. It is closely followed by South Africa, Tanzania, Kenya and Uganda. It was therefore a nightmare when Nigeria, like the rest of Africa, woke up to the fall armyworm (FAW) infestation that is rapidly spreading across the region. The five zones affected by the infestation include the southeast, south, southwest, northeast and northwest.

[Chief Audu Ogbeh, Minister of Agriculture and Rural Development] said the federal government required N2.98 billion to curb the armyworm infestation in farmlands across the country, adding the United Nations Food and Agriculture Organization (FAO) had pledged to support the country in its fight against the armyworm.

However, scientists are calling on farmers to embrace biotechnology by using genetically engineered (GE) crops, which have been proven safe for humans and the environment, to permanently tackle such occurrences.

[Dr. Rose Gidado, the country coordinator of the Open Forum on Agricultural Biotechnology (OFAB)] said adopting genetic modification technology to develop maize varieties resistant to pests offered a lasting solution for army worm infestation, adding that GE plants are selectively bred and enhanced with genes to withstand common problems that confront farmers.

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion and analysis. Read full, original post: Food shortages loom as Nigeria battles fall armyworm infestation

Related Stories

Original post:
Fall armyworm threatens Nigerian crops; genetic engineering offers ... - Genetic Literacy Project

Read More...

Nanomedicine – Overview

September 6th, 2017 7:49 pm

The program began in 2005 with a national network ofeight Nanomedicine Development Centers. Now, in the second half of this 10-year program, the four centers best positioned to effectively apply their findings to translational studies were selected to continue receiving support.

Nanomedicine, an offshoot of nanotechnology, refers to highly specific medical intervention at the molecular scale for curing disease or repairing damaged tissues, such as bone, muscle, or nerve. A nanometer is one-billionth of a meter, too small to be seen with a conventional lab microscope. It is at this size scale about 100 nanometers or less that biological molecules and structures operate in living cells.

The NIH vision for Nanomedicine is built upon the strengths of NIH funded researchers in probing and understanding the biological, biochemical and biophysical mechanisms of living tissues. Since the cellular machinery operates at the nanoscale, the primary goal of the program - characterizing the molecular components inside cells at a level of precision that leads to re-engineering intracellular complexes - is a monumental challenge.

The teams selected to carry out this initiative consist of researchers with deep knowledge of biology and physiology, physics, chemistry, math and computation, engineering, and clinical medicine. The choice and design of experimental approaches are directed by the need to solve clinical problems (e.g., treatment of sickle cell disease, blindness, cancer, and Huntingtons disease). These are very challenging problems, and great breakthroughs are needed to achieve the goals within the projected 10 year timeframe. The initiative was selected for the NIH Roadmap (now Common Fund) precisely because of the challenging, high risk goals, and the NIH team is working closely with the funded investigators to use the funds and the intellectual resources of the network of investigators to meet those challenges.

10 Year Program Design High Risk, High Reward

The Centers were funded with the expectation that the first half of the initiative would be more heavily focused on basic science with increased emphasis on application of this knowledge in the second five years. This was a novel, experimental approach to translational medicine that began by funding basic scientists interested in gaining a deep understanding of an intracellular nanoscale system and necessitated collaboration with clinicians from the outset in order to properly position work at the centers so that during the second half of the initiative, studies would be applied directly to medical applications. The program began witheight Nanomedicine Development Centers(NDCs), and four centers remain in the second half of the program.

Clinical Consulting Boards (CCBs)

The program has establishedClinical Consulting Boards (CCBs)for each of the continuing centers. These boards consist of at least three disease-specific clinician-scientists who are experts in the target disease(s). The intent is for CCBs to provide advice and insight into the needs and barriers regarding resource and personnel allocations as well as scientific advice as needed to help the centers reach their translational goals. Each CCB reports directly to the NIH project team.

Translational Path

In 2011, the PIs of the NDCs worked with their CCBs to precisely define their translational goals and the translational research path needed to reach those goals by the end of the initiative in 2015. To facilitate this, the NIH project team asked them to developcritical decision pointsalong their path. These critical decision points differ from distinct milestones because they may be adjusted based on successes, challenges, barriers, and progress. Similarly, the timing of these decision points may be revised as the centers progress. Research progress and critical decision points are revisited several times a year by the CCB and the NIH team, and when a decision point is reached, next steps are re-examined for relevance, feasibility and timing.

Transition plan

Throughout the program, various projects have been spun off of work at all the centers and most have received funding from other sources. This was by design as work at each center has been shifting from basic science to translational studies. Centers will not be supported by the common fund after 10 years. It is expected that work at the centers will be more appropriately funded by other sources. Pre-clinical targets will likely be developed, and the work at each center will be focused on a specific disease so the work will need to transition out of the experimental space of the common fund.

Support for the NIH Nanomedicine Initiative is provided by the NIH Common Fund, and a team of staff members from across the NIH oversees the program. You may direct questions or comments on the NIH Nanomedicine Initiative to Dr. Richard S. Fisher, Nanomedicine Project Team Leader (nano@nih.gov).

Read this article:
Nanomedicine - Overview

Read More...

Page 937«..1020..936937938939..950960..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick